Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.33M Buy
+9,193
New +$3.15M 0.23% 105
2024
Q4
Sell
-694
Closed -$224K 364
2024
Q3
$224K Sell
694
-53
-7% -$17.3K 0.03% 322
2024
Q2
$233K Buy
+747
New +$219K 0.03% 304

Other funds holding AMGN

Nilsine Partners's AMGN Position: Q2 2026 in Review

Nilsine Partners opened a new position in Amgen (AMGN) in Q2 2026: 9,193 shares worth $3.33M. The stake represents 0.23% of the portfolio and ranks #105 among its holdings. This is a return to the name: Nilsine Partners previously reported a position in AMGN as recently as Q3 2024.

Nilsine Partners first reported a position in AMGN in Q2 2024 and has held it in 3 quarters since. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Nilsine Partners held 9,193 shares of Amgen worth $3.33M as of Q2 2026.
  • Amgen was a new Nilsine Partners position in Q2 2026.
  • Amgen made up 0.23% of Nilsine Partners's portfolio in Q2 2026, its #105 holding.
  • Nilsine Partners first reported a position in Amgen in Q2 2024 and has held it in 3 quarters since.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Nilsine Partners's 13F filing for Q2 2026, filed 24 Jul 2026.